Keith Lenden
Founder of Boundless Bio
Keith Lenden
Founder of Boundless Bio
San Carlos, California
Overview
Work Experience
Venture Partner
2017 - Current
ARCH Venture Partners is a leading biotechnology and pharmaceutical venture capital firm
Co-Founder
2018
Autobahn Therapeutics is a CNS focused drug discovery and development company founded on technology from the Oregon Health & Science University
Co-Founder
2018
Boundless Bio is an ecDNA focused oncology drug discovery and development company founded on technology from the Ludwig Cancer Research Institute at UCSD
Co-Founder
2011 - 2019
Abide Therapeutics was a serine hydrolase inhibitor drug discovery and development company founded on technology from the Scripps Research Institute that was acquired by Lundbeck in 2019
Co-Founder
2008 - 2015
Receptos (NASDAQ: RCPT) was a GPCR drug discovery and development company founded on technology from the Scripps Research Institute and acquired by Celgene in 2015 (now BMS)
Vice President, Corporate Development & Strategy
2013 - 2015
Esperion Therapeutics (NASDAQ: ESPR) is a cardiovascular drug development company
Vice President, Product & Business Development
2007 - 2013
Maxygen was a biotechnology discovery and product development company
Senior Director, Business Development
2004 - 2007
Acologix was a renal focused drug development company
Director, Business Development
2001 - 2004
Genteric was a gene therapy and drug delivery company
Consultant
1995 - 1999
LEK Consulting is a leading biotechnology strategy consulting organization